632 related articles for article (PubMed ID: 34554630)
21. Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy.
Theiler RN; Wick M; Mehta R; Weaver AL; Virk A; Swift M
Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100467. PubMed ID: 34425297
[TBL] [Abstract][Full Text] [Related]
22. Associations of COVID-19 vaccination during pregnancy with adverse neonatal and maternal outcomes: A systematic review and meta-analysis.
Ding C; Liu Y; Pang W; Zhang D; Wang K; Chen Y
Front Public Health; 2023; 11():1044031. PubMed ID: 36794075
[TBL] [Abstract][Full Text] [Related]
23. Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study.
McClymont E; Atkinson A; Albert A; Av-Gay G; Andrade J; Barrett J; Bogler T; Boucoiran I; Castillo E; D'Souza R; El-Chaâr D; Fadel S; Fell DB; Korchinski I; Kuret V; Ogilvie G; Poliquin V; Sadarangani M; Scott H; Snelgrove JW; Tunde-Byass M; Money D;
Vaccine; 2023 Nov; 41(48):7183-7191. PubMed ID: 37865598
[TBL] [Abstract][Full Text] [Related]
24. Obstetric and Early Neonatal Outcomes Following Second and Third COVID-19 Vaccination in Pregnancy.
Peretz-Machluf R; Gilboa M; Bookstein-Peretz S; Segal O; Regev N; Meyer R; Regev-Yochay G; Yinon Y; Toussia-Cohen S
Isr Med Assoc J; 2024 Jan; 26(1):12-17. PubMed ID: 38420636
[TBL] [Abstract][Full Text] [Related]
25. Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy.
Jorgensen SCJ; Drover SSM; Fell DB; Austin PC; D'Souza R; Guttmann A; Buchan SA; Wilson SE; Nasreen S; Schwartz KL; Tadrous M; Wilson K; Kwong JC
JAMA Pediatr; 2023 Dec; 177(12):1314-1323. PubMed ID: 37870875
[TBL] [Abstract][Full Text] [Related]
26. Effects of Covid-19 Vaccination during Pregnancy on the Obstetric and Neonatal Outcomes in a Tertiary Health Care Center.
Tripathy GS; Rath TS; Behera S; Lekha KS; Kar D; Pendyala S
J Mother Child; 2023 Jun; 27(1):72-78. PubMed ID: 37409659
[TBL] [Abstract][Full Text] [Related]
27. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
28. Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil.
Tavares Veras Florentino P; Cerqueira-Silva T; Freire De Carvalho L; Jôse Oliveira Alves F; De Araújo Oliveira V; Mateus Oliveira Aguilar G; De Sousa Prado R; Soranz D; Pearce N; Boaventura V; Loreiro Werneck G; Oliveira Penna G; Lima Barreto M; Henrique De Oliveira Garcia M; Barral-Netto M; Santos da Paixão E
Int J Epidemiol; 2023 Dec; 52(6):1708-1715. PubMed ID: 37690066
[TBL] [Abstract][Full Text] [Related]
29. No observable influence of COVID-19 inactivated vaccines on pregnancy and birth outcomes in the first trimester of gestation.
Du T; Qu Q; Zhang Y; Huang Q
Expert Rev Vaccines; 2023; 22(1):900-905. PubMed ID: 37843409
[TBL] [Abstract][Full Text] [Related]
30. Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination.
Vesco KK; Denoble AE; Lipkind HS; Kharbanda EO; DeSilva MB; Daley MF; Getahun D; Zerbo O; Naleway AL; Jackson L; Williams JTB; Boyce TG; Fuller CC; Weintraub ES; Vazquez-Benitez G
Obstet Gynecol; 2024 Jun; 143(6):794-802. PubMed ID: 38626447
[TBL] [Abstract][Full Text] [Related]
31. Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose.
Nevo L; Cahen-Peretz A; Vorontsov O; Frenkel R; Kabessa M; Cohen SM; Hamrani A; Oiknine-Djian E; Lipschuetz M; Goldman-Wohl D; Walfisch A; Kovo M; Neeman M; Yagel S; Wolf DG; Beharier O
Am J Obstet Gynecol; 2022 Sep; 227(3):486.e1-486.e10. PubMed ID: 35430228
[TBL] [Abstract][Full Text] [Related]
32. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
34. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
35. Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
Norman M; Magnus MC; Söderling J; Juliusson PB; Navér L; Örtqvist AK; Håberg S; Stephansson O
JAMA; 2024 Feb; 331(5):396-407. PubMed ID: 38319332
[TBL] [Abstract][Full Text] [Related]
36. Inactivated COVID-19 vaccines in peri-pregnancy period: Evaluation of safety for both pregnant women and neonates.
Yang C; Zheng Z; Zheng P; Chen J; Huang Q; Chen Y; Zhou Y; Chen P; Li Y; Wu Y
Vaccine; 2023 Nov; 41(49):7450-7459. PubMed ID: 37949755
[TBL] [Abstract][Full Text] [Related]
37. Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19.
Di Mascio D; Sen C; Saccone G; Galindo A; Grünebaum A; Yoshimatsu J; Stanojevic M; Kurjak A; Chervenak F; Rodríguez Suárez MJ; Gambacorti-Passerini ZM; Baz MLAA; Aguilar Galán EV; López YC; De León Luis JA; Hernández IC; Herraiz I; Villalain C; Venturella R; Rizzo G; Mappa I; Gerosolima G; Hellmeyer L; Königbauer J; Ameli G; Frusca T; Volpe N; Luca Schera GB; Fieni S; Esposito E; Simonazzi G; Di Donna G; Youssef A; Della Gatta AN; Di Donna MC; Chiantera V; Buono N; Sozzi G; Greco P; Morano D; Bianchi B; Lombana Marino MG; Laraud F; Ramone A; Cagnacci A; Barra F; Gustavino C; Ferrero S; Ghezzi F; Cromi A; Laganà AS; Laurita Longo V; Stollagli F; Sirico A; Lanzone A; Driul L; Cecchini D F; Xodo S; Rodriguez B; Mercado-Olivares F; Elkafrawi D; Sisti G; Esposito R; Coviello A; Cerbone M; Morlando M; Schiattarella A; Colacurci N; De Franciscis P; Cataneo I; Lenzi M; Sandri F; Buscemi R; Gattei G; Sala FD; Valori E; Rovellotti MC; Done E; Faron G; Gucciardo L; Esposito V; Vena F; Giancotti A; Brunelli R; Muzii L; Nappi L; Sorrentino F; Vasciaveo L; Liberati M; Buca D; Leombroni M; Di Sebastiano F; Di Tizio L; Gazzolo D; Franchi M; Ianniciello QC; Garzon S; Petriglia G; Borrello L; Nieto-Calvache AJ; Burgos-Luna JM; Kadji C; Carlin A; Bevilacqua E; Moucho M; Pinto PV; Figueiredo R; Morales Roselló J; Loscalzo G; Martinez-Varea A; Diago V; Jimenez Lopez JS; Aykanat AY; Cosma S; Carosso A; Benedetto C; Bermejo A; May Feuerschuette OH; Uyaniklar O; Ocakouglu SR; Atak Z; Gündüz R; Haberal ET; Froessler B; Parange A; Palm P; Samardjiski I; Taccaliti C; Okuyan E; Daskalakis G; Moreira de Sa RA; Pittaro A; Gonzalez-Duran ML; Guisan AC; Genç ŞÖ; Zlatohlávková B; Piqueras AL; Oliva DE; Cil AP; Api O; Antsaklis P; Ples L; Kyvernitakis I; Maul H; Malan M; Lila A; Granese R; Ercoli A; Zoccali G; Villasco A; Biglia N; Madalina C; Costa E; Daelemans C; Pintiaux A; Cueto E; Hadar E; Dollinger S; Brzezinski Sinai NA; Huertas E; Arango P; Sanchez A; Schvartzman JA; Cojocaru L; Turan S; Turan O; Di Dedda MC; Molpeceres RG; Zdjelar S; Premru-Srsen T; Cerar LK; Druškovič M; De Robertis V; Stefanovic V; Nupponen I; Nelskylä K; Khodjaeva Z; Gorina KA; Sukhikh GT; Maruotti GM; Visentin S; Cosmi E; Ferrari J; Gatti A; Luvero D; Angioli R; Puri L; Palumbo M; D'Urso G; Colaleo F; Chiara Rapisarda AM; Carbone IF; Mollo A; Nazzaro G; Locci M; Guida M; Di Spiezio Sardo A; Panici PB; Berghella V; Flacco ME; Manzoli L; Bifulco G; Scambia G; Zullo F; D'Antonio F
J Perinat Med; 2020 Nov; 48(9):950-958. PubMed ID: 32975205
[TBL] [Abstract][Full Text] [Related]
38. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
39. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
40. The relationship between COVID-19 vaccination status in pregnancy and birthweight.
Gaur P; Darwin KC; Kohn JR; Uribe KA; Shippey E; Eke AC
Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101057. PubMed ID: 37330010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
